Welcome to our dedicated page for Albemarle SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Albemarle Corporation filings document operating results, material events, governance matters, shareholder voting items, and capital-structure disclosures for a public specialty chemicals and critical materials company. Form 8-K reports cover quarterly financial results, credit agreement amendments, debt-related actions, board appointments, officer transitions, and completed portfolio transactions.
Proxy materials describe director elections, committee governance, executive compensation, shareholder proposals, and voting procedures. Albemarle's filing record also documents the completed disposition of a controlling stake in Ketjen, retained ownership interests, integration of Performance Catalyst Solutions, and financing arrangements tied to the company's global lithium, bromine and specialty product businesses.
Albemarle Corporation filed an update describing changes to its Board of Directors. Effective February 26, 2026, the Board appointed Michelle T. Collins and Mark R. Widmar as independent directors. Collins joined the Audit & Finance and Governance & Public Policy Committees, while Widmar joined the Executive Compensation & Talent Development and Safety, Sustainability, Operations & Capital Committees.
Under Albemarle’s non-employee director compensation program, each new director will receive an annual cash retainer of $120,000, paid quarterly and prorated for their partial initial term, plus an annual grant of restricted stock valued at $170,000, rounded to the nearest 25 shares and prorated for the partial year. The company states there are no special arrangements behind their selection and no related-party transactions requiring disclosure. A press release dated March 2, 2026, further announcing these appointments is furnished as an exhibit.
Albemarle Corporation’s Chief Commercial Officer Eric Norris reported equity compensation activity involving company common stock. He acquired 1,806 shares on February 26, 2026 at $184.93 per share through the vesting of previously granted Performance Stock Units, bringing his direct holdings to 49,738 shares.
On the same date, 785 shares at $184.93 per share were disposed of to cover tax liabilities tied to the 2023 Performance Stock Unit grant vesting. After this tax-withholding disposition, Norris held 48,953 shares of Albemarle common stock directly.
Albemarle Corp executive Mark Richard Mummert reported equity award activity involving company common stock. On February 26, 2026, he acquired 366 shares at $184.93 per share through a grant/award tied to Performance Stock Units originally granted on February 24, 2023. The footnotes explain that these units were split between ROIC and rTSR Performance Stock Units and that all shares earned vested on February 26, 2026. On the same date, 159 shares at $184.93 per share were disposed of to cover tax liabilities associated with this vesting. Following these transactions, he held 14,372 shares of Albemarle common stock directly.
Albemarle Corp executive Melissa H. Anderson reported equity compensation activity involving the company’s common stock. On February 26, 2026, she acquired 1,129 shares through the vesting of Performance Stock Units that were originally granted on February 24, 2023, split between ROIC and rTSR performance awards.
On the same date, 491 shares were disposed of to cover tax liabilities related to this vesting, as a tax-withholding disposition rather than an open‑market sale. After these transactions, she directly owned 9,512 shares of Albemarle common stock and also indirectly held 179.1617 shares through the Albemarle Savings Plan as of this Form 4.
Albemarle Corporation senior vice president Cynthia Renee Lima reported equity compensation activity involving company common stock. On 02/26/2026, she acquired 147 shares at $184.93 per share through the vesting of Performance Stock Units that were originally granted on 02/24/2023.
According to the disclosure, 50% of those Performance Stock Units were based on ROIC performance and 50% on relative total shareholder return, and all shares earned vested on 02/26/2026. On the same date, 64 shares at $184.93 per share were disposed of to cover tax liabilities associated with the vesting, leaving her with 12,642 directly owned shares after these transactions.
Albemarle Corp General Counsel & Secretary Ander C. Krupa reported equity compensation activity involving common stock. On 2/26/2026, she acquired 173 shares at $184.93 per share through a grant or award tied to Performance Stock Units granted on 2/24/2023. On the same date, 80 shares at $184.93 per share were disposed of to satisfy tax liabilities related to the vesting of those units. After these transactions, she directly owned 11,388 common shares.
Albemarle Corp Chief People Officer Autumn M. Gagarinas reported equity compensation activity involving common stock. She acquired 194 shares on February 26, 2026 as a grant tied to Performance Stock Units granted on February 24, 2023, when all earned shares vested. On the same date, 85 shares were disposed of through a tax-withholding transaction to cover liabilities from that vesting. After these transactions, she directly owned 3,597 common shares.
Albemarle Corporation director Mark R. Widmar reported receiving a grant of 325 Phantom Stock units on February 26, 2026. These units convert on a one-for-one basis into Albemarle common stock and are payable as shares upon events established under the company’s 2023 Directors Plan.
The Phantom Stock units have no expiration date. This grant represents a pro‑rata portion of his annual non‑employee director stock compensation under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for Non‑Employee Directors, and the shares are scheduled to vest on July 1, 2026.
Albemarle Corporation executive Donald J. LaBauve Jr., VP, Corporate Controller & CAO, reported stock-based compensation activity in common stock. He received grants or vesting-related acquisitions of 1,266 shares on February 27, 2026 and 219 shares on February 26, 2026.
The filing also shows 361 shares and 67 shares were disposed of on those dates solely to cover tax liabilities tied to restricted stock unit vesting. In addition, 12,755 shares are held indirectly in the Albemarle Savings Plan as of the Form 4 date.
ALBEMARLE CORP Chairman & CEO J Kent Masters reported equity compensation activity involving company common stock. He acquired 9,032 shares at $184.93 per share as a grant or award, bringing his direct holdings to 127,885 shares immediately after this acquisition and 123,961 shares after related tax withholding.
The shares came from Performance Stock Units granted on 02/24/2023, with 50% tied to ROIC performance and 50% to relative total shareholder return (rTSR). No shares were earned under the ROIC component, while all shares under the rTSR component vested on 02/26/2026.
To cover tax liabilities from this vesting, 3,924 shares were disposed of through share withholding at $184.93 per share, which is a tax-withholding disposition rather than an open-market sale.